Business
Charlotte's Web and University of Colorado-Boulder Collaborating on Sleep and Anxiety Studies
Charlotte's Web and University of Colorado-Boulder Collaborating on Sleep and Anxiety Stu...

About this update from Charlotte's Web Holdings, Inc.
[{"type":"text","content":"\n \n \n \n Charlotte's Web and University of Colorado-Boulder Collaborating on Sleep and Anxiety Studies\n \n \n /* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n.prntac{\nTEXT-ALIGN: CENTER\n}\n \n \n \n \n \n \n Canada NewsWire\n \n \n \n \n \n \n \n Research Assesses CBD and CBN's Potential to Support Improved Sleep\n \n \n \n \n BOULDER, Colo.\n \n ,\n \n June 2, 2021\n \n /CNW/ - (TSX: CWEB) (OTCQX: CWBHF) Charlotte's Web Holdings, Inc. (\"Charlotte's Web\" or the \"Company\"), the market leader in hemp CBD wellness products and a Certified B Corporation, today announced the collaboration of its CW Labs division on a preclinical sleep and anxiety study with the\n \n University of Colorado-Boulder's\n \n REACH (Research and Education Addressing Cannabis and Health) Center. The scientific investigation uses the Company's full spectrum hemp formulations with CBN (cannabinol) and CBD (cannabidiol) and levels of THC below 0.3% to examine the impact on anxiety and sleep quality. The Company is the only hemp CBD brand supporting the\n \n University of Colorado\n \n REACH Center's milestone study.\n \n \n \n \n \n \n \n \n \n There is limited published preclinical or clinical data on phytocannabinoids other than CBD and THC, especially their effect at levels available in commercially sold hemp-derived CBD supplements. There is some anecdotal evidence on the ability of CBN to help with sleep but little substantiated clinical or preclinical evidence to validate these pervasive claims. Long term, it is anticipated that this study will inform future clinical initiatives to better understand how specific ratios of cannabinoids and different delivery formats are effective at supporting improved sleep quality and instilling healthier sleep architecture in humans.\n \n \n \"Charlotte's Web is committed to advancing science on the benefits and safety of CBD and other hemp phytocannabinoids through rigorous scientific investigations such as this sleep and anxiety study,\" said\n \n Tim Orr\n \n , Senior Vice President of Charlotte's Web and President of its CW Labs division, which current...